Improved virologic outcomes over time for HIV-infected patients on antiretroviral therapy in a cohort from Rio de Janeiro, 1997–2011
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Improved virologic outcomes over time for HIV-infected patients on antiretroviral therapy in a cohort from Rio de Janeiro, 1997–2011 ; volume:14 ; number:1 ; day:11 ; month:6 ; year:2014 ; pages:1-10 ; date:12.2014
BMC infectious diseases ; 14, Heft 1 (11.6.2014), 1-10, 12.2014
- Urheber
-
Martin, David A.
- Beteiligte Personen und Organisationen
-
Luz, Paula M.
Lake, Jordan E.
Clark, Jesse L.
Veloso, Valdilea G.
Moreira, Ronaldo I.
Cardoso, Sandra W.
Klausner, Jeffrey D.
Grinsztejn, Beatriz
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-14-322
- URN
-
urn:nbn:de:1111-2016030317343
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Martin, David A.
- Luz, Paula M.
- Lake, Jordan E.
- Clark, Jesse L.
- Veloso, Valdilea G.
- Moreira, Ronaldo I.
- Cardoso, Sandra W.
- Klausner, Jeffrey D.
- Grinsztejn, Beatriz
- SpringerLink (Online service)
Ähnliche Objekte (12)
Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study
Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children
Interruption of antiretroviral treatment in HIV-infected children
Impact of peer support on virologic failure in HIV-infected patients on antiretroviral therapy - a cluster randomized controlled trial in Vietnam
Durability of antiretroviral therapy and predictors of virologic failure among perinatally HIV-infected children in Tanzania: a four-year follow-up
Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda
Decreased bone turnover in HIV-infected children on antiretroviral therapy
Platelet activity in HIV-infected patients on abacavir-containing antiretroviral therapy
Prevalence of testosterone deficiency in HIV-infected men under antiretroviral therapy
Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon
Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM)
Immune correlates of CD4 decline in HIV-infected patients experiencing virologic failure before undergoing treatment interruption
Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study
Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children
Interruption of antiretroviral treatment in HIV-infected children
Impact of peer support on virologic failure in HIV-infected patients on antiretroviral therapy - a cluster randomized controlled trial in Vietnam
Durability of antiretroviral therapy and predictors of virologic failure among perinatally HIV-infected children in Tanzania: a four-year follow-up
Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda
Decreased bone turnover in HIV-infected children on antiretroviral therapy
Platelet activity in HIV-infected patients on abacavir-containing antiretroviral therapy
Prevalence of testosterone deficiency in HIV-infected men under antiretroviral therapy
Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon
Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM)
Immune correlates of CD4 decline in HIV-infected patients experiencing virologic failure before undergoing treatment interruption
Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study
Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children
Interruption of antiretroviral treatment in HIV-infected children
Impact of peer support on virologic failure in HIV-infected patients on antiretroviral therapy - a cluster randomized controlled trial in Vietnam
Durability of antiretroviral therapy and predictors of virologic failure among perinatally HIV-infected children in Tanzania: a four-year follow-up
Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda
Decreased bone turnover in HIV-infected children on antiretroviral therapy
Platelet activity in HIV-infected patients on abacavir-containing antiretroviral therapy
Prevalence of testosterone deficiency in HIV-infected men under antiretroviral therapy
Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon
Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM)